Download PDF
Am J Perinatol 2024; 41(S 01): e156-e162
DOI: 10.1055/a-1850-4429
Original Article

Severe Fetal CAKUT (Congenital Anomalies of the Kidneys and Urinary Tract), Prenatal Consultations, and Initiation of Neonatal Dialysis

Keia R. Sanderson
1   Department of Medicine-Nephrology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
,
Weiwen V. Shih
2   Department of Pediatrics-Nephrology, Children's Hospital Colorado, University of Colorado, Aurora, Colorado
,
Bradley A. Warady
3   Division of Nephrology, Children's Mercy Kansas City, Kansas City, Missouri
,
Donna J. Claes
4   Department of Pediatrics, Division of Nephrology and Hypertension, University of Cincinnati College of Medicine, Cincinnati, Ohio
› Author Affiliations Funding Dr. Warady is supported by that National Institutes of Health, through Grant U01DK66143. Dr. Sanderson is supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR002490 and Grant 2015213 from the Doris Duke Charitable Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
› Further Information
Also available at
    Permissions and Reprints

Abstract

Introduction Pediatric nephrology prenatal consultations for congenital anomalies of the kidney and urinary tract (CAKUT) and criteria for kidney replacement therapy initiation in neonatal end-stage kidney disease (ESKD) are not well described. We evaluated pediatric nephrology approaches to prenatal CAKUT counseling and neonatal dialysis initiation.

Methods A 35-question Qualtrics survey was distributed via the North American Pediatric Renal Trials and Collaborative Studies email list between January and March 2021. Thirty-nine pediatric nephrology centers completed the survey.

Results All but one responding center (n = 38) provide prenatal CAKUT consultations and neonatal dialysis, with wide variability in reported multispecialty involvement. Nearly half (47%) of centers utilize written/unwritten criteria for offering neonatal dialysis. The most common contraindications to neonatal dialysis were parental refusal (61%), contraindication to access placement by surgeons (55%), and birth weight (BW) contraindication (55%, with < 1,500 g being the most common BW contraindication). Overall, 79% of centers reported caring for < 5 neonates with ESKD in the past year, 61% use hemodialysis therapies prior to peritoneal dialysis in neonates requiring dialysis, and 100% transition to peritoneal dialysis by hospital discharge.

Conclusion Many pediatric nephrology programs provide prenatal CAKUT consultations and neonatal dialysis, but with variability in practice approach. Further multicenter research regarding prenatal consultations and neonatal dialysis outcomes is necessary to further improve care delivery to this population.

Keywords

peritoneal dialysis - chronic peritoneal dialysis - chronic hemodialysis - pediatric ESKD - infants - neonates


Publication History

Received: 01 December 2021

Accepted: 06 May 2022

Accepted Manuscript online:
12 May 2022

Article published online:
10 June 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Talati AN, Webster CM, Vora NL. Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT). Prenat Diagn 2019; 39 (09) 679-692
    CrossrefPubMedGoogle Scholar
  • 2 Nassr AA, Shazly SAM, Abdelmagied AM. et al. Effectiveness of vesicoamniotic shunt in fetuses with congenital lower urinary tract obstruction: an updated systematic review and meta-analysis. Ultrasound Obstet Gynecol 2017; 49 (06) 696-703
    CrossrefPubMedGoogle Scholar
  • 3 Morris RK, Malin GL, Quinlan-Jones E. et al; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstructioxxn (PLUTO) Collaborative Group. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 2013; 382 (9903): 1496-1506
    CrossrefPubMedGoogle Scholar
  • 4 Carey WA, Talley LI, Sehring SA, Jaskula JM, Mathias RS. Outcomes of dialysis initiated during the neonatal period for treatment of end-stage renal disease: a North American Pediatric Renal Trials and Collaborative Studies special analysis. Pediatrics 2007; 119 (02) e468-e473
    CrossrefPubMedGoogle Scholar
  • 5 Askenazi D, Ingram D, White S. et al. Smaller circuits for smaller patients: improving renal support therapy with Aquadex™. Pediatr Nephrol 2016; 31 (05) 853-860
    CrossrefPubMedGoogle Scholar
  • 6 Schürch B, Manegold-Brauer G, Schönberger H. et al. Diagnostic accuracy of an interdisciplinary tertiary center evaluation in children referred for suspected congenital anomalies of the kidney and urinary tract on fetal ultrasound - a retrospective outcome analysis. Pediatr Nephrol 2021; 36 (12) 3885-3897
    CrossrefPubMedGoogle Scholar
  • 7 Klein J, Buffin-Meyer B, Boizard F. et al; BIOMAN consortium. Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease. Kidney Int 2021; 99 (03) 737-749
    CrossrefPubMedGoogle Scholar
  • 8 Moscardi PRM, Katsoufis CP, Jahromi M. et al. Prenatal renal parenchymal area as a predictor of early end-stage renal disease in children with vesicoamniotic shunting for lower urinary tract obstruction. J Pediatr Urol 2018; 14 (04) 320.e1-320.e6
    CrossrefPubMedGoogle Scholar
  • 9 Saccone G, D'Alessandro P, Escolino M. et al. Antenatal intervention for congenital fetal lower urinary tract obstruction (LUTO): a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2020; 33 (15) 2664-2670
    CrossrefPubMedGoogle Scholar
  • 10 Stacey D, Légaré F, Lewis K. et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 2017; 4 (04) CD001431
    PubMedGoogle Scholar
  • 11 Sanderson KR, Yu Y, Dai H, Willig LK, Warady BA. Outcomes of infants receiving chronic peritoneal dialysis: an analysis of the USRDS registry. Pediatr Nephrol 2019; 34 (01) 155-162
    CrossrefPubMedGoogle Scholar
  • 12 Vidal E, van Stralen KJ, Chesnaye NC. et al; ESPN/ERA-EDTA Registry. Infants requiring maintenance dialysis: outcomes of hemodialysis and peritoneal dialysis. Am J Kidney Dis 2017; 69 (05) 617-625
    CrossrefPubMedGoogle Scholar
  • 13 Carey WA, Martz KL, Warady BA. Outcome of patients initiating chronic peritoneal dialysis during the first year of life. Pediatrics 2015; 136 (03) e615-e622
    CrossrefPubMedGoogle Scholar
  • 14 Geary DF. Attitudes of pediatric nephrologists to management of end-stage renal disease in infants. J Pediatr 1998; 133 (01) 154-156
    CrossrefPubMedGoogle Scholar
  • 15 Teh JC, Frieling ML, Sienna JL, Geary DF. Attitudes of caregivers to management of end-stage renal disease in infants. Perit Dial Int 2011; 31 (04) 459-465
    CrossrefPubMedGoogle Scholar
  • 16 Ranchin B, Plaisant F, Demède D, de Guillebon JM, Javouhey E, Bacchetta J. Review: Neonatal dialysis is technically feasible but ethical and global issues need to be addressed. Acta Paediatr 2021; 110 (03) 781-788
    CrossrefPubMedGoogle Scholar
  • 17 Wightman AG, Freeman MA. Update on ethical issues in pediatric dialysis: has pediatric dialysis become morally obligatory?. Clin J Am Soc Nephrol 2016; 11 (08) 1456-1462
    CrossrefPubMedGoogle Scholar
  • 18 Lantos JD, Warady BA. The evolving ethics of infant dialysis. Pediatr Nephrol 2013; 28 (10) 1943-1947
    CrossrefPubMedGoogle Scholar
  • 19 Bunchman TE. The ethics of infant dialysis. Perit Dial Int 1996; 16 (Suppl. 01) S505-S508
    CrossrefPubMedGoogle Scholar
  • 20 Ledermann SE, Scanes ME, Fernando ON, Duffy PG, Madden SJ, Trompeter RS. Long-term outcome of peritoneal dialysis in infants. J Pediatr 2000; 136 (01) 24-29
    CrossrefPubMedGoogle Scholar
  • 21 Streuli JC, Staubli G, Pfändler-Poletti M, Baumann-Hölzle R, Ersch J. Five-year experience of clinical ethics consultations in a pediatric teaching hospital. Eur J Pediatr 2014; 173 (05) 629-636
    CrossrefPubMedGoogle Scholar
  • 22 Loos S, Kemper MJ. Causes of renal oligohydramnios: impact on prenatal counseling and postnatal outcome. Pediatr Nephrol 2018; 33 (04) 541-545
    CrossrefPubMedGoogle Scholar
  • 23 Mehler K, Gottschalk I, Burgmaier K. et al. Prenatal parental decision-making and postnatal outcome in renal oligohydramnios. Pediatr Nephrol 2018; 33 (04) 651-659
    CrossrefPubMedGoogle Scholar
  • 24 Carter B, Brockman M, Garrett J, Knackstedt A, Lantos J. Why are there so few ethics consults in children's hospitals?. HEC Forum 2018; 30 (02) 91-102
    CrossrefPubMedGoogle Scholar
  • 25 Bioethics C. Palliative care for children. Pediatrics 2000; 106 (2 Pt 1): 351-357
    CrossrefPubMedGoogle Scholar
  • 26 Bourdens M, Tadonnet J, Hostalery L, Renesme L, Tosello B. Severe fetal abnormality and outcomes of continued pregnancies: a French multicenter retrospective study. Matern Child Health J 2017; 21 (10) 1901-1910
    CrossrefPubMedGoogle Scholar
  • 27 Kukora S, Gollehon N, Laventhal N. Antenatal palliative care consultation: implications for decision-making and perinatal outcomes in a single-centre experience. Arch Dis Child Fetal Neonatal Ed 2017; 102 (01) F12-F16
    CrossrefPubMedGoogle Scholar
  • 28 Hope KD, Bhat PN, Dreyer WJ. et al. Pediatric palliative care in the heart failure, ventricular assist device and transplant populations: supporting patients, families and their clinical teams. Children (Basel) 2021; 8 (06) 468
    PubMedGoogle Scholar
  • 29 Knoll C, Kaufman B, Chen S. et al. Palliative care engagement for pediatric ventricular assist device patients: a single-center experience. ASAIO J 2020; 66 (08) 929-932
    CrossrefPubMedGoogle Scholar
  • 30 Craig F, Henderson EM, Patel B, Murtagh FEM, Bluebond-Langner M. Palliative care for children and young people with stage 5 chronic kidney disease. Pediatr Nephrol 2022; 37 (01) 105-112
    CrossrefPubMedGoogle Scholar
  • 31 Akchurin OM, Kogon AJ, Kumar J. et al. Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report. BMC Nephrol 2017; 18 (01) 181
    CrossrefPubMedGoogle Scholar